Abstract:Human ageing, along with the ageing of conventional model organisms, is depicted as a continuous and progressive decline of biological capabilities accompanied by an exponentially increasing mortality risk. However, not all organisms experience ageing identically and our understanding of the phenomenon is coloured by human-centric views. Ageing is multifaceted and influences a diverse range of species in varying ways. Some undergo swift declines post-reproduction, while others exhibit insubstantial changes throughout their existence. This vast array renders defining universally applicable "ageing attributes" a daunting task. It is nonetheless essential to recognize that not all ageing features are organism-specific. These common attributes have paved the way for identifying "hallmarks of ageing," processes that are intertwined with age, amplified during accelerated ageing, and manipulations of which can potentially modulate or even reverse the ageing process. Yet, a glaring observation is that individuals within a single population age at varying rates. To address this, demographers have coined the term 'frailty'. Concurrently, scientific advancements have ushered in the era of molecular clocks. These innovations enable a distinction between an individual's chronological age (time since birth) and biological age (physiological status and mortality risk). In 2011, the "Smurf" phenotype was unveiled in Drosophila, delineating an age-linked escalation in intestinal permeability that presages imminent mortality. It not only acts as a predictor of natural death but identifies individuals exhibiting traits normally described as age-related. Subsequent studies have revealed the phenotype in organisms like nematodes, zebrafish, and mice, invariably acting as a death predictor. Collectively, these findings have steered our conception of ageing towards a framework where ageing is not linear and continuous but marked by two distinct, necessary phases, discernible in vivo, courtesy of the Smurf phenotype. This framework includes a mathematical enunciation of longevity trends based on three experimentally measurable parameters. It facilitates a fresh perspective on the evolution of ageing as a function. In this article, we aim to delineate and explore the foundational principles of this innovative framework, emphasising its potential to reshape our understanding of ageing, challenge its conventional definitions, and recalibrate our comprehension of its evolutionary trajectory.

Molecular and physiological manifestations and measurement of aging in humans

EPIGENETIC PROFILES OF BIOLOGICAL AGING HALLMARKS

Aging:A Life Science Approach

Molecular and phenotypic biomarkers of aging

Key Molecular Mechanisms of Aging, Biomarkers, and Potential Interventions

Comprehensive Insights from Molecular Targets and Biomarkers to Biological Clocks

Molecular and phenotypic biomarkers of aging [version 1; referees: 3 approved]

Molecular damage in aging

Molecular mechanisms of aging and anti-aging strategies

Eleven Telomere, Epigenetic Clock, and Biomarker-Composite Quantifications of Biological Aging: Do They Measure the Same Thing?

Quantification of biological aging in young adults

Epigenomic, Transcriptome And Image-Based Biomarkers Of Aging

A molecular index for biological age identified from the metabolome and senescence‐associated secretome in humans

Measuring biological age using omics data

Biomarkers of Cellular Senescence and Aging: Current State-of-the-Art, Challenges and Future Perspectives

The cellular mechanobiology of aging: from biology to mechanics

High-dimensional Ageome Representations of Biological Aging across Functional Modules

The molecular mechanism of aging and the role in neurodegenerative diseases

Biomarkers of aging in real life: three questions on aging and the comprehensive geriatric assessment

A complex systems approach to aging biology

Ageing as a two-phase process: theoretical framework